Illicit Drug Supply and Market Integrity

Addresses risks related to counterfeit, unauthorized, and fraudulent weight-loss drug products, including illicit supply channels, consumer scams, regulatory enforcement, patent infringement, and reputational threats to legitimate manufacturers in the context of high-demand markets.